This comprehensive review analyzes cutting-edge tools and technologies in modern pharmaceutical research, focusing on ...

US medical giants say Australia’s Pharmaceutical Benefits Scheme is an “egregious and discriminatory” program that Trump ...

Youngkin vetoed for the second straight year a widely backed bill to raise Virginia’s minimum wage that would have allowed it ...

Novo Nordisk’s hopes of heralding a new era of obesity treatment with its next-generation CagriSema drug may be in doubt ...

It comes as the PM pledged that a re-elected Labor government would cap PBS-listed medications at $25, a promise the ...

If you believed everything you read on social media, you’d think HHS Secretary Robert F. Kennedy Jr. had issued a sweeping ...

The British pharmaceutical giant is working with the U.K. Dementia Research Institute to exploit a “natural randomization” ...

Equities research analysts at Zacks Research reduced their FY2025 earnings per share (EPS) estimates for Catalyst ...

If Mölndal were shut down, it would spell the end for Sweden as a major player in global pharma research. The country has a large number of small biotech companies, and one or two speciality ...

China’s growing influence on pharmaceutical research and development represents a significant wildcard for the industry in 2025. The country’s clinical trial landscape continues to expand ...

Glenmark Pharmaceuticals Ltd. (Glenmark), a leading research-led, global pharmaceuticals company has partnered with, Health ...